Program I standing unquestionably boosts the volume of complexity for just about any investigation study. One example is, all researchers—regardless of whether preclinical or clinical—will have to receive Routine I study registrations. 21 CFR area 1301.18. Against this, researchers that have DEA Practitioner registrations in Schedules II–V (w